folder Filed in Health, Policy
Understanding Cannabis: Medicine and Society
Peter Cervieri

Dana Rohrabacher, R-CA, U.S. Congress.

Topics include Rohrabacher-Farr amendment, Jeff Sessions, federal drug enforcement policy, states rights, descheduling cannabis.

Lori Ajax, Chief, Bureau of Medical Cannabis Regulation

Daniele Piomelli, Professor of Anatomy and Neurobiology, University of California, Irvine

Senator Joe Dunn, Assistant Dean of External Relations, UC Irvine School of Law

Senator Dunn talks about the need for democrats and republicans to come together on issues they agree on (cannabis law and regulations), and the creation of an academic based, interdisciplinary cannabis research institute that is tied to no ideology or specific position, and bases its positions solely on academic research.

Dr. Daniel P. Menard, Founder, MyCROSite

Dr. Menard talks about the beginnings of his cannabis research in 1995-1996. Cannabis was surprisingly more effective than the opiodes his team in Montreal was previously using in the lab as an analgesic to treat pain.

According to Dr. Menard, pain affects more Americans than diabetes, heart disease, and cancer combined. According to the National Center for Health Statistics, approximately 76.2 million (that’s one in every four Americans), have suffered from pain that lasts longer than 24 hours and millions more suffer from acute pain. Pain is cited as the most common reason Americans access the health care system, it is a leading cause of disability, and it is a major contributor to health care costs.

As such a serious expense to our country and a barrier to a joyful or even just a tolerable life, pain has rightfully been addressed by science. Still, our present solutions have rendered additional and undesirable consequences. Opiate abuse continues to rise, and while our citizens look for relief from their pain, our solutions to their pain issues has unfortunately eliminated not only pain, but often coherence, cognition, and far too frequently lives.

Additionally, as many as 1 in 4 people who receive prescription opioids long term for non-cancer pain in primary care settings struggles with addiction, and over 1,000 people are treated daily in emergency departments for misusing prescription opioids. With more than 50,000 deaths resulting from opiate overdoses in 2016 and 13,000 deaths from heroin overdoses (a 23% increase from 2015), our present pain solutions are not helping people, they are killing them.

New developments in Cannabis provide healthier, more effective, life-changing, and perhaps even life-saving alternatives and solutions to PTSD, pain, and many of the maladies which affect us on a daily basis. Conferences and symposiums like this one are an essential step in progressing with sharing information and continuing to educate the public and consumers on the developments in Cannabis research and the alternative products and therapies available to our country.

Anita Sabine, Partner, Manatt, Phelps & Phillips, talks about the California Cannabis Trailer Bill Intent Language and the need for banking.